Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Operating Activities    
Net loss $ (7,127) $ (13,900)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,802 4,111
Amortization of deferred lease incentive (19) (34)
Deferred income tax expense 0 9
Provision for doubtful accounts 177 169
Reserve for note receivable 0 350
Provision for excess and slow moving inventory (8) 12
Stock-based compensation expense 1,004 1,604
Deferred rent 2 2
Amortization of debt issuance and discount costs 254 631
Loss on early extinguishment of debt 1,706 182
Warrant modification expense 0 803
Change in fair value of warrant liability 56 (404)
Fair value adjustment of contingent consideration liability 0 35
Gain on sale of assets (5,546) (1,700)
Changes in operating assets and liabilities:    
Accounts receivable 2,465 (499)
Inventory (202) 414
Prepaid expenses and other assets (146) 439
Accounts payable 498 (1,023)
Accrued expenses and other liabilities (2,500) (1,000)
Net Cash Used in Operating Activities (7,584) (9,799)
Investing Activities    
Proceeds from sale of assets 29,000 3,412
Purchase of improvements and equipment 89 (126)
Issuance of bridge loan 0 (350)
Release of escrow deposit 300 0
Net Cash Provided by Investing Activities 29,389 2,936
Financing Activities    
Contingent purchase price payments 0 (675)
Net proceeds from bridge loan 1,712 0
Repayment of long-term debt (14,135) (1,618)
Fees paid on early extinguishment of debt (466) (32)
Net proceeds from issuance of common stock 0 5,865
Payment of withholding taxes related to stock-based employee compensation (2) (151)
Net Cash (Used In) Provided by Financing Activities (12,891) 3,389
Net Increase (Decrease) in Cash and Cash Equivalents 8,914 (3,474)
Cash and Cash Equivalents - Beginning of period 2,181 5,580
Cash and Cash Equivalents - End of period 11,095 2,106
Supplemental Disclosure of Cash Flows Information    
Interest 362 1,008
Non-cash investing and financing activities:    
2016 Accrued bonus awarded in equity 0 374
2015 Accrued bonus awarded in equity 0 0
Common stock issued for contingent purchase price payments $ 0 $ 1,175